Association between related purine metabolites and diabetic retinopathy in type 2 diabetic patients

45Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims. The purpose of the study was to investigate the differences of adenosine, adenine, inosine, xanthine, hypoxanthine, and uric acid concentrations in patients with type 2 diabetes mellitus and diabetic retinopathy and assess the relationship between purine metabolites and disease. Materials and Methods. The study group consisted of 114 subjects which were divided into three groups: control (n=40), type 2 diabetes without retinopathy (n=35), and type 2 diabetes with retinopathy (n=39). Levels of metabolites were measured in plasma of all participants. Results. There is a significant increase of levels of adenosine (0.94±0.17 mg/L versus 0.17±0.01 mg/L, P<0.001), inosine (0.297±0.078 mg/L versus 0.086±0.010 mg/L, P<0.001), xanthine (1.01±0.21 mg/L versus 0.54±0.05 mg/L, P=0.009), and uric acid (70.55±3.97 mg/L versus 53.81±2.36 mg/L, P<0.001) with diabetic retinopathy compared to diabetes mellitus. The levels of adenine, hypoxanthine, and xanthine oxidase did not change. Uric acid, xanthine, inosine, and adenosine correlated positively with systolic blood pressure and urea nitrogen. Conclusions. The levels of adenosine, inosine, uric acid, and xanthine may be useful for monitoring the progression of diabetic retinopathy and evaluating the treatment. © 2014 Jianfei Xia et al.

Cite

CITATION STYLE

APA

Xia, J., Wang, Z., & Zhang, F. (2014). Association between related purine metabolites and diabetic retinopathy in type 2 diabetic patients. International Journal of Endocrinology, 2014. https://doi.org/10.1155/2014/651050

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free